Department of Urology Archives

Prostate cancer survivors symposium set for Nov. 11

Oct. 12, 2023—Vanderbilt University Medical Center Department of Urology and Vanderbilt-Ingram Cancer Center are hosting a symposium for prostate cancer survivors and their families on Saturday, Nov. 11.

New leaders named to Vanderbilt-Ingram research programs

Aug. 10, 2023—Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center’s research programs.

A Vanderbilt Institute for Surgery and Engineering team working to create a navigational system to decrease stone fragments left behind after surgery includes Nicholas Kavoussi, MD, left, Ipek Oguz, PhD, and Daiwei Lu. (photo by Susan Urmy)

VISE team works to develop 3D navigation system to better treat kidney stones

Aug. 8, 2023—A multidisciplinary team at Vanderbilt is working to create a real-time navigational system to decrease residual stone fragments left behind after kidney stone surgery.

Overactive bladder and anxiety

Apr. 20, 2023—Anxiety and psychological stress impact hypersensitivity mechanisms in women that could contribute to overactive bladder — a frequent and sudden urge to urinate that is difficult to control.

More U.S. prostate cancer patients choosing active surveillance

Apr. 3, 2023—A Vanderbilt study found the number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with favorable intermediate-risk cancers.

Roger Dmochowski, MD, with Female Pelvic Medicine and Reconstructive Surgery Urology fellows Stephanie Gleicher, MD, MPH, left, who graduates in June, and Rosa Park, MD.

Urology fellowship program celebrated after 20 years

Mar. 30, 2023—The urology fellowship training program focused on women’s urologic health and reconstruction, known as Female Pelvic Medicine and Reconstructive Surgery, is celebrating its 20th anniversary and graduating its 20th fellow in June at Vanderbilt University Medical Center.

E. coli uses serine to abide acidity

Mar. 23, 2023—Vanderbilt researchers have discovered another acid resistance mechanism for UTI-causing E. coli, laying the foundation for targeted antibacterial therapies.

Mark Cuban pharmacy could save billions on prostate cancer, bladder drugs

Feb. 9, 2023—Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs.

Study reveals pathways for aggressive prostate cancer subtype

Oct. 27, 2022—Research from Vanderbilt-Ingram Cancer Center has revealed new information about the molecular pathways of cribriform prostate cancer.

Gender differences with bladder pain

Sep. 26, 2022—Gender differences in the pain experiences and treatment needs of people with a urologic pain syndrome could be used to improve interventions, Vanderbilt researchers report.

Maria Hadjifrangiskou, PhD, Connor Beebout, PhD, and colleagues are studying why the bacterium E. coli is so tenacious.

Study describes how E. coli co-opts cells, causes recurrent UTIs

Aug. 25, 2022—Researchers at Vanderbilt University Medical Center have discovered why the uropathogenic bacterium E. coli, the leading cause of urinary tract infections, is so tenacious; their findings could lead to new ways to prevent recurrent UTIs.